|
Celebrex v. Vioxx Information
The popular and heavily advertised
arthritis drug Celebrex has been linked by researchers to
an increase in the risk of blood, clots, heart attacks,
strokes, and even sudden death. In some cases it has been
learned that Pharmacia, the manufacturer of Celebrex,
failed to disclose all of its research data. Individuals
have been harmed by the negligence of the giant
pharmaceutical companies, and can receive compensation for
their injuries.
Celebrex side effects have not been studied as intensively
as those of Vioxx, although many experts believe Celebrex
side effects will be identical, since both drugs are
classified as Cox-2 inhibitors.
75 Million Americans have taken Celebrex, there is
evidence to suggest that heart complications caused by
Vioxx, could also effect patients taking Celebrex.
Celebrex has been linked to several very serious, and
sometimes life threatening, medical conditions:
Possible side effects that could indicate serious medical
problems while using Celebrex include:
If you or a loved one have taken Celebrex
or Vioxx and experienced
any of the above side effects, you may have a right to
seek compensation from the drug companies that have caused
you pain.
At Brown & Crouppen our experienced team of Celebrex
& Vioxx
defective drug lawyers provide tough, aggressive
representation for victims and their families.
When you choose us to handle your Celebrex or Vioxx lawsuit, our
entire team becomes fully committed to your cause.
We’ll
find answers, hold negligent companies responsible and get
you the compensation you deserve.
You can count on Brown &
Crouppen for top-notch legal skills and our commitment to
making the justice system work for you. If you have legal
concerns and would like to benefit from the support of a
strong team of pharmaceutical lawyers, please call our
office today at 1-800-536-HELP
or contact us
online for a
FREE Vioxx
Case Evaluation and find out why so many people
believe that with Brown & Crouppen “bigger is
better”.
Celebrex
Facts
-
Forecasters estimate Celebrex sales for 2005 are $996
million;
-
Cox-2 inhibitors and arthritis drugs are a $5.4 billion
per year market in the United States alone, with
Celebrex accounting for $2.6 billion of those sales,
according to IMS Health;
-
Pfizer’s Celebrex has a 43% market share of the
arthritis drug market ,and its newcomer, Bextra, is at
22%. Merck's arthritis drug Vioxx controlled 35% of the
market.
-
An Oct. 7 editorial in the New England Journal of
Medicine by a drug researcher at the University of
Pennsylvania said that all COX-2 drugs suppress a factor
that keeps the walls of blood vessels healthy. The data
from animal tests is enough to keep patients and doctors
worried about all COX-2 drugs.
Back to top
Copyright - US Vioxx Lawyers - Brown & Crouppen
- St. Louis, Missouri
Vioxx Lawyers, Celebrex, Dangerous Drug Litigators,
Pharmaceutical Negligence, Arthritis Drug Attorneys,
Unsafe Drugs, Osteoarthritis, Cox-2 Inhibitors, Heart
Attack, Stroke, Kidney Problems, Vioxx News Alert,
Recall
Site by
Consultwebs.com,
Inc. - Webs for
Lawyers | Law Firms, News by
LegalNewsFeeds.com. |
|